Collaborative Arrangements and Acquisitions Collaborative Arrangements and Acquisitions - Kymera Therapeutics (Details) - Kymera Therapeutics $ in Millions	1 Months Ended
May 31, 2019 USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Collaborative arrangement, up-front payment	$ 50.0
Collaborative arrangement, development and regulatory potential milestone payments maximum	170.0
Collaborative Arrangement, Investment in Collaborative Partner, Amount	$ 20.0

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration